h1

h2

h3

h4

h5
h6


001     1007251
005     20250513050442.0
024 7 _ |a eva569549
|2 HSB
024 7 _ |a 0732-183X
|2 ISSN
024 7 _ |a 1527-7755
|2 ISSN
024 7 _ |a SCOPUS:2-s2.0-85196284347
|2 SCOPUS
024 7 _ |a WOS:001270735700012
|2 WOS
024 7 _ |a 10.1200/JCO.23.01983
|2 doi
024 7 _ |a pmid:38657187
|2 pmid
024 7 _ |a 10.18154/RWTH-CONV-253622
|2 datacite_doi
037 _ _ |a RWTH-CONV-253622
041 _ _ |a English
100 1 _ |0 P:(DE-82)1011577
|a Klümper, Niklas
|b 0
|e Corresponding author
|u rwth
245 _ _ |a NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer
|h online
260 _ _ |a Alexandria, Va.
|b American Society of Clinical Oncology
|c 2024
336 7 _ |0 0
|2 EndNote
|a Journal Article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
591 _ _ |a Austria
591 _ _ |a Canada
591 _ _ |a Germany
591 _ _ |a Netherlands
591 _ _ |a USA
700 1 _ |0 P:(DE-82)1011578
|a Tran, Ngoc Khanh
|b 1
|u rwth
700 1 _ |a Zschäbitz, Stefanie
|b 2
700 1 _ |a Hahn, Oliver
|b 3
700 1 _ |0 P:(DE-82)1011579
|a Büttner, Thomas
|b 4
|u rwth
700 1 _ |a Roghmann, Florian
|b 5
700 1 _ |a Bolenz, Christian
|b 6
700 1 _ |a Zengerling, Friedemann
|b 7
700 1 _ |a Schwab, Constantin
|b 8
700 1 _ |0 P:(DE-82)1011580
|a Nagy, Dora
|b 9
|u rwth
700 1 _ |0 P:(DE-82)118426
|a Toma, Marieta
|b 10
|u rwth
700 1 _ |0 P:(DE-82)022727
|a Kristiansen, Glen
|b 11
|u rwth
700 1 _ |a Heers, Hendrik
|b 12
700 1 _ |a Ivanyi, Philipp
|b 13
700 1 _ |a Niegisch, Günter
|b 14
700 1 _ |a Grunewald, Camilla Marisa
|b 15
700 1 _ |a Darr, Christopher
|b 16
700 1 _ |a Farid, Arian
|b 17
700 1 _ |a Schlack, Katrin
|b 18
700 1 _ |a Abbas, Mahmoud
|b 19
700 1 _ |a Aydogdu, Can
|b 20
700 1 _ |a Casuscelli, Jozefina
|b 21
700 1 _ |a Mokry, Theresa
|b 22
700 1 _ |a Mayr, Michael
|b 23
700 1 _ |a Niedersüß-Beke, Dora
|b 24
700 1 _ |a Rausch, Steffen
|b 25
700 1 _ |a Dietrich, Dimo
|b 26
700 1 _ |a Saal, Jonas
|b 27
700 1 _ |a Ellinger, Jörg
|b 28
700 1 _ |0 P:(DE-82)1011581
|a Ritter, Manuel
|b 29
|u rwth
700 1 _ |a Alajati, Abdullah
|b 30
700 1 _ |0 P:(DE-588)1016467567
|a Kuppe, Christoph
|b 31
|u rwth
700 1 _ |a Meeks, Joshua
|b 32
700 1 _ |a Vera Badillo, Francisco E.
|b 33
700 1 _ |a Nakauma-González, J. Alberto
|b 34
700 1 _ |a Boormans, Joost
|b 35
700 1 _ |a Junker, Kerstin
|b 36
700 1 _ |a Hartmann, Arndt
|b 37
700 1 _ |a Grünwald, Viktor
|b 38
700 1 _ |a Hölzel, Michael
|b 39
700 1 _ |a Eckstein, Markus
|b 40
773 _ _ |0 PERI:(DE-600)2005181-5
|a 10.1200/JCO.23.01983
|n 20
|p 2446-2455
|t Journal of clinical oncology : JCO
|v 42
|x 1527-7755
856 4 _ |u https://publications.rwth-aachen.de/record/1007251/files/1007251.pdf
|y OpenAccess
909 C O |o oai:publications.rwth-aachen.de:1007251
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)1011577
|a RWTH Aachen
|b 0
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)1011578
|a RWTH Aachen
|b 1
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)1011579
|a RWTH Aachen
|b 4
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)1011580
|a RWTH Aachen
|b 9
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)118426
|a RWTH Aachen
|b 10
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)022727
|a RWTH Aachen
|b 11
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)1011581
|a RWTH Aachen
|b 29
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-588)1016467567
|a RWTH Aachen
|b 31
|k RWTH
914 1 _ |y 2024
915 1 _ |0 StatID:(DE-HGF)0031
|2 StatID
|a Peer reviewed article
|x 0
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-06
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J CLIN ONCOL : 2022
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-06
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-06
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a IF >= 40
|0 StatID:(DE-HGF)9940
|2 StatID
|b J CLIN ONCOL : 2022
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-01-06
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2025-01-06
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-06
920 1 _ |0 I:(DE-82)952020_20230811
|k 952020
|l Lehr- und Forschungsgebiet Quantitative Zelldynamik und translationale Systembiologie
|x 0
920 1 _ |0 I:(DE-82)531020-2_20140620
|k 531020-2
|l Klinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Nephrologie und Immunologie)
|x 1
970 _ _ |a eva569549
980 _ _ |a I:(DE-82)531020-2_20140620
980 _ _ |a I:(DE-82)952020_20230811
980 _ _ |a UNRESTRICTED
980 _ _ |a VDB
980 _ _ |a journal
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21